nafronyl has been researched along with Mental Disorders in 2 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hronek, J | 1 |
| Laciga, Z | 1 |
| Vanková, H | 1 |
| Vencovský, E | 1 |
| Lehmann, HE | 1 |
1 trial available for nafronyl and Mental Disorders
| Article | Year |
|---|---|
[Use of Dusodril (naphtidrofuryl) in treatment of gerontopsychiatric patients (author's transl)].
Topics: Age Factors; Aged; Clinical Trials as Topic; Female; Furans; Humans; Intracranial Arteriosclerosis; | 1977 |
1 other study available for nafronyl and Mental Disorders
| Article | Year |
|---|---|
New psychoactive drugs in psychogeriatrics.
Topics: Aged; Animals; Guinea Pigs; Humans; Meclofenoxate; Mental Disorders; Nafronyl; Psychotropic Drugs; P | 1976 |